The legislation has no chance of passing the Republican-controlled Senate, and the White House has issued a veto threat. Still, Democrats saw a victory in the message their bill sends to voters.
As a hammer to force companies to negotiate, House Speaker Nancy Pelosi would impose steep sales taxes on the medications at issue. Overall, budget analysts estimated the legislation would cut industry revenues by $500 billion to $1 trillion over 10 years.
As open enrollment goes into the home stretch Thanksgiving week, critics say the new tool can create confusion by obscuring out-of-pocket costs that seniors should factor into their decisions.
President Trump is instead backing a bipartisan bill that would for the first time limit what seniors have to pay out of their own pockets for medications.
Presidential candidate Elizabeth Warren’s plan is built on transferring to the government 98% of the $8.8 trillion she estimates that employers will spend on private insurance for their employees.
President Donald Trump and House Speaker Nancy Pelosi could hardly be more at odds—but behind the scenes, they’re still grasping at a bipartisan deal to lower the cost of prescription drugs.
The regulations are now seen as an obstacle to progress because Medicare has put a premium on coordination among care providers. The complex requirements of the original rules can have a chilling effect on hospitals and doctors working together, officials say.
While the price of almost any good or service can be found online, most Americans don’t know what they’ll owe for a prescription medication until they get it.
The treatment costs $375,000 or $475,000, depending on whether it is used for advanced lymphoma or pediatric leukemia. Hospital stays can add hundreds of thousands of dollars to the cost of care.
A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday.
Iowa Republican Charles Grassley and Oregon Democrat Ron Wyden said the bill would for the first time limit drug copays for people with Medicare’s “Part D” prescription plan, by capping patients’ out-of-pocket costs.
The Trump administration’s top Medicare official used an annual report on the program’s fiscal outlook to attack proposals by some Democrats to expand government health-care coverage to all Americans.
Federal agents on Tuesday broke up a billion-dollar Medicare scam that peddled unneeded orthopedic braces to hundreds of thousands of seniors.
Verma, a protege of Vice President Mike Pence and the architect of Indiana’s Medicaid expansion, appears to have steered agency money to political allies in an effort to boost her reputation, prominent Democrats say.
“Medicare-for-all” makes a good first impression, but support plunges when people are asked if they’d pay higher taxes or put up with treatment delays to get it.
The penalties will be as much as 2 percent of Medicare reimbursements, and could be worth millions of dollars to large nursing-home chains with locations spread across Indiana and the nation.
Indiana hospitals are racking up millions of dollars in penalties for having too many patients return for care within a month of discharge.
The Trump administration said Thursday it will allow states to require "able-bodied" Medicaid recipients to work, a hotly debated first in the enormous program's half-century history.